Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients

Immunol Today. 1999 Aug;20(8):343-7. doi: 10.1016/s0167-5699(98)01428-5.

Abstract

Resistance to engraftment of bone marrow transplants appears to be mediated by host-derived cytotoxic T-cell precursors that survive supralethal conditioning. Here, Yair Reisner and Massimo Martelli review engraftment studies showing that escalation of haematopoietic progenitor cell dose induces transplantation tolerance, thereby overcoming major genetic histocompatibility barriers.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bone Marrow Transplantation* / immunology
  • HLA Antigens
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immune Tolerance
  • Leukemia / immunology
  • Leukemia / therapy*
  • Mice
  • Radiation Chimera / immunology

Substances

  • HLA Antigens